Results 211 to 220 of about 101,340 (329)

Erratum to “estimation of the interstitial free concentration of the putative dopamine D3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats” [Neurosci. Lett. 193 (1995) 65–67]

, 1995
Raul R. Gainetdinov, Tatyana D. Sotnikova, Tatyana V. Grekhova, K.S. Rayevsky   +3 more
openalex   +1 more source

Recent Developments in the Optical Control of Adrenergic Signaling

Medicinal Research Reviews, EarlyView.
ABSTRACT Adrenoceptors (ARs) play a vital role in various physiological processes and are key therapeutic targets. The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution. In this review, we summarize the latest advancements in the
Shuang Shi, Yangzhi Cao, Maikel Wijtmans, Henry F. Vischer, Rob Leurs   +4 more
wiley   +1 more source

Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes. [PDF]

JCEM Case Rep
Sahota S, Cooper L, Sirkova A, Stojanovic N.   +3 more
europepmc   +1 more source

Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit. [PDF]

R Soc Open Sci, 2021
Wahba MEK, El Wasseef D, El Sherbiny D.
europepmc   +1 more source

Effects of the dopamine D2 agonist, quinpirole, on time and number processing in rats [PDF]

, 2001
Angelo Santi, Romina Coppa, Lori E. Ross
openalex   +1 more source

The Quinoline Photoremovable Group (PPG) Platform—A Medicinal Chemist's Approach for Photocage Development and Applications

Medicinal Research Reviews, EarlyView.
ABSTRACT Photoremovable protecting groups (PPGs) offer a straightforward solution for the temporary inactivation of biologically active substrates and their subsequent controlled release by light irradiation. Their relatively easy design and mode of application have made them useful tools for studying dynamic biological processes in vitro and in vivo ...
Bence Kontra, Zoltán Mucsi, Janez Ilaš, Petra Dunkel   +3 more
wiley   +1 more source

Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor [PDF]

, 2002
Michael Lamey, Miles D. Thompson, George Varghese, Hong Chi, Marek Sawzdargo, Susan R. George, Brian F. O’Dowd   +6 more
openalex   +1 more source

Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets

Movement Disorders, EarlyView.
Margaret Walshe, Julia Hirschwald, Tobias Warnecke   +2 more
wiley   +1 more source

Molecular Tools to Study and Control Dopaminergic Neurotransmission With Light

Medicinal Research Reviews, EarlyView.
ABSTRACT Dopaminergic neurotransmission is involved in several important brain functions, such as motor control, learning, reward‐motivated behavior, and emotions. Dysfunctions of dopaminergic system may lead to the development of various neurological and psychiatric disorders, like Parkinson's disease, schizophrenia, depression, and addictions ...
Galyna Maleeva, Carlo Matera, Silvia Roda, Alessio Colleoni, Marco De Amici, Pau Gorostiza   +5 more
wiley   +1 more source

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight. [PDF]

BMC Endocr Disord
Caprio S, Pilli T, Cantara S, Sestini F, Fioravanti C, Ciuoli C, Dalmiglio C, Corbo A, Castagna MG.   +8 more
europepmc   +1 more source